HomePLUR • TLV
add
Pluri Inc
Previous close
ILAÂ 1,572.00
Day range
ILAÂ 1,578.00 - ILAÂ 1,589.00
Year range
ILAÂ 1,535.00 - ILAÂ 2,999.20
Market cap
23.51M USD
Avg Volume
7.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 326.00K | 503.70% |
Operating expense | 5.40M | -0.61% |
Net income | -5.88M | -18.56% |
Net profit margin | -1.80K | 80.36% |
Earnings per share | — | — |
EBITDA | -5.13M | 3.33% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.66M | -23.65% |
Total assets | 35.44M | -20.43% |
Total liabilities | 35.50M | 5.97% |
Total equity | -63.00K | — |
Shares outstanding | 5.56M | — |
Price to book | -16.38 | — |
Return on assets | -34.67% | — |
Return on capital | -39.47% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -5.88M | -18.56% |
Cash from operations | -4.06M | 30.61% |
Cash from investing | 585.00K | -89.92% |
Cash from financing | — | — |
Net change in cash | -3.46M | -3,461.86% |
Free cash flow | -3.11M | 29.73% |
About
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas. Wikipedia
CEO
Founded
May 11, 2001
Headquarters
Website
Employees
112
